MBIO:NASDAQ
Mustang Bio Inc
USD 0,47
arrow_upward
+1,16%(+0,0054) 1D
2 Okt., 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MBIO...
Open
USD 0,47
High
USD 0,48
Low
USD 0,46
Mkt. cap
3,55 m
Avg. vol.
24,50 k
Volume
33,39 k
52-wk high
USD 1,84
52-wk low
USD 0,46
EPS
-USD 0,46
Beta
2,09
Shares outstanding
6,73 m
No. of employees
4
Open
USD 0,47
High
USD 0,48
Low
USD 0,46
Mkt. cap
3,55 m
Avg. vol.
24,50 k
Volume
33,39 k
52-wk high
USD 1,84
52-wk low
USD 0,46
EPS
-USD 0,46
Beta
2,09
Shares outstanding
6,73 m
No. of employees
4
News stories
From web sources and news partners
MarketBeat
·
11 minute gelede
Atlanticus (NASDAQ:ATLC) Stock Rating Lowered by Wall Street Zen
Seeking Alpha
·
52 minute gelede
September's Leaders And Laggards
Yahoo Finance
·
1 uur gelede
BillionToOne (NasdaqGS:BLLN) Stock Fair Value Edges Higher As Analysts Weigh Tech And Reimbursement Risk
Profile
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
About Mustang Bio Inc
CEOManuel Litchman
Employees4
Founded2015
HeadquartersWaltham, Massachusetts, Verenigde State van Amerika
Sector-
Websitemustangbio.com